IgA is principally expressed in the body's mucous membranes, particularly in the respiratory and gastrointestinal tracts where IgA is involved in the control of viral infections [30] as the earliest neutralizing antibody response to SARS‐CoV‐2 infection [31]. The gene discussed is CD79A; the disease is viral infectious disease.